293480.KS
Hana Pharm Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 8,230.00
+0.73%Year over year
Reported trailing growth
- Revenue
- +7.5%
- EBITDA
- -34.5%
- EBIT
- +16.8%
- EPS
- -14.7%
- Free cash flow
- —
- Operating cash flow
- -33.7%
Forward estimates
Based on analyst estimates
- Revenue
- -73.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- -0.8%
- EBIT
- -6.0%
- Net income
- -28.8%
- EPS
- -28.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026